Why synthetic peptides come as TFA or acetate salts, how the counter-ion changes weighed mass and assay results, and how laboratories measure or exchange it.
A referenced review of BPC-157 research: sequence and identifiers, the cell and animal studies, who produced them, human trial status, and TGA and WADA status.
What a BPC-157 and TB-500 blend contains, how each peptide is identified by HPLC and mass spectrometry, and what published research covers each component.
BPC-157 and TB-500 compared: where each sequence comes from, their structures and identifiers, the studies behind each, and their TGA and WADA status.
CJC-1295 with and without DAC compared: the shared 29-residue sequence, the albumin-reactive lysine linker, how labs tell the forms apart, and WADA status.
How CJC-1295 and ipamorelin are built, which pituitary receptors they act on, what published studies and trial registries hold, and their WADA status.
What endotoxin, elemental impurity and residual solvent results on a peptide COA measure, the methods behind them, and why they matter in cell-culture work.
GHK-Cu is the copper complex of the tripeptide GHK. Its discovery, copper-binding chemistry, cell and animal studies, and TGA and WADA status, with references.
How laboratories test multi-component peptide blends: separating each peptide, confirming its identity by mass spectrometry and measuring each one on its own.
A section-by-section guide to reading a peptide certificate of analysis: batch details, identity, HPLC purity, peptide content, counter-ions and other tests.
A guide to reading peptide research: study types, NHMRC levels of evidence, what to check in methods and results, and how to find retractions and trials.
What WHO guidance and published studies say about storing sealed lyophilised peptides in the lab: temperature, moisture, light, oxygen and record keeping.
How HPLC purity is measured for synthetic peptides, how the percentage is calculated, and what it leaves out, from water and counter-ions to hidden impurities.
KLOW combines BPC-157, GHK-Cu, TB-500 and KPV: what each peptide is, the cell and animal research on each, how the blend is tested and its Australian status.
KLOW and the BPC-157 and TB-500 blend compared: composition, the two shared peptides, the research on each pairing, testing differences and Australian status.
KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-MSH. Its structure, the cell and mouse studies, open mechanism questions, and its TGA and WADA status.
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. A referenced review of its cell, animal and human studies, identity data and regulatory status.
MOTS-c is encoded in mitochondrial DNA; SS-31 is a synthetic tetrapeptide. How their origin, structure, studied mechanisms, evidence and status compare.
NAD+ explained: its structure, redox chemistry, the enzymes that consume it, how it differs from NMN and NR, how labs measure it, and its TGA and WADA status.
What net peptide content means, why it differs from the gross weight of a lyophilised peptide powder, and how laboratories measure counter-ions and water.
Plain-English definitions of 50 peptide terms from research papers and certificates of analysis: chemistry, synthesis, lab testing, study types and regulation.
How mass spectrometry confirms a synthetic peptide's identity: ionisation, m/z values, charge states, MS/MS sequencing, mass accuracy and the limits of a match.
Where BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, GHK-Cu, KPV, SS-31 and NAD+ sit on the 2026 WADA Prohibited List, and how it applies in Australia.
How solid-phase peptide synthesis builds a peptide on resin beads, what Fmoc and Boc chemistry do, and which impurities purification and testing look for.
SS-31 (elamipretide) is a synthetic tetrapeptide that binds cardiolipin in mitochondria. A referenced review of its studies, trial record and FDA history.
What published research on TB-500 covers: its structure, the thymosin beta-4 studies it is based on, the limits of the evidence, and its status in Australia.
TB-500 and thymosin beta-4 compared: sequence, length, molecular weight, how the research on each differs, and their Australian regulatory status, with sources.
A plain-English primer on peptides: amino acids, the peptide bond, how sequences are written, where peptides end and proteins begin, and common modifications.
What preclinical research is, why most published work on research peptides stops at cell and animal studies, and how to read those findings with care.
How freeze-drying works, why water drives peptide degradation and what residual moisture means for lyophilised research peptides, with cited sources.
